Chr | NA |
start | NA |
end | NA |
lncRNA name | LOC284454 |
entrez id | NA |
hgnc id | NA |
ensg id | NA |
refseq id | NA |
methods | RNA-seq, RT-qPCR, Western blot, in vitro knockdown, RIP |
regulated | down-regulated |
function description | Expression of LOC284454 is significantly reduced in breast, prostate, uterus and kidney cancer and also in breast cancer cell lines (MCF7 and T47D). Global gene expression studies upon loss and gain of function of LOC284454 revealed perturbation of genes related to cancer-related pathways. Focal adhesion and cell migration pathway genes are downregulated under overexpression condition, and these genes are significantly upregulated in breast cancer cell lines as well as breast cancer tissue samples suggesting a functional role of LOC284454 lncRNA in breast cancer pathobiology. |
pubmed id | 29227193 |
year | 2017 |
title | DDX5/p68 associated lncRNA LOC284454 is differentially expressed in human cancers and modulates gene expression. |
drug | X |
circulating | X |
survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China